Skip to main content
. 2020 Jul 3;11:3303. doi: 10.1038/s41467-020-17150-3

Table 1.

Localized PDAC patient characteristics at the time of blood draw for CTC purification.

ID Age (yrs) Sex CA19-9 (U/mL) CEA (ng/mL) T stage N stage M stage Stage
locPDAC01 82 M 224 3.6 2 2 0 III
locPDAC02 49 F 566 1.1 2 0 0 I
locPDAC03 70 M 40 4.7 1 0 0 I
locPDAC04 72 M 82 5 1 2 0 II
locPDAC05 65 M 1943 4.8 2 0 0 I
locPDAC06 74 F 289 2.5 3 0 0 II
locPDAC07 59 F 418 2.9 2 0 0 I
locPDAC08 61 M 179 2 1 1 0 II
locPDAC09 60 M 132 3.2 2 0 0 I
locPDAC10 89 F 11.7 24 3 0 0 II
locPDAC11 50 F 1040 8.3 2 0 0 I
locPDAC12 66 F 2 1.5 1 0 0 I
locPDAC13 83 F 19 1.5 1 2 0 II
locPDAC14 69 M 63 4.9 2 1 0 II
locPDAC15 69 F 369 5.4 3 2 0 III
locPDAC16 76 M 15 3.2 2 0 0 I
locPDAC17 75 F 70 2.1 2 0 0 I